All-trans-retinoic acid suppresses interferon-γ and tumor necrosis factor-α; a possible therapeutic agent for rheumatoid arthritis

Rheumatology International

Volumn 26, Issue 9, 2006, Pages 810-817

  Nozaki, Yuji ^a   Tamaki, Chise ^a   Yamagata, Toshiaki ^a   Sugiyama, Masafumi ^a   Ikoma, Shinya ^a   Kinoshita, Koji ^a   Funauchi, Masanori ^a  

^a KINKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

All trans retinoic acid; Autoimmune disease; Cytokine; Th1 Th2 cells

Indexed keywords

CHEMOKINE RECEPTOR CCR4; CHEMOKINE RECEPTOR CCR5; GAMMA INTERFERON; INTERLEUKIN 2; INTERLEUKIN 4; RETINOIC ACID; STAT6 PROTEIN; TUMOR NECROSIS FACTOR ALPHA;

ADOLESCENT; ADULT; AGED; ARTICLE; AUTOIMMUNE DISEASE; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL PROLIFERATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; INTERFERON PRODUCTION; NITROBLUE TETRAZOLIUM TEST; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; TH1 CELL; TH2 CELL; WESTERN BLOTTING;

ADOLESCENT; ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CYTOKINES; HUMANS; INTERFERON TYPE II; INTERFERON-GAMMA; LEUKOCYTES, MONONUCLEAR; MIDDLE AGED; RECEPTORS, CCR4; RECEPTORS, CCR5; RECEPTORS, CHEMOKINE; REFERENCE VALUES; RNA, MESSENGER; STAT6 TRANSCRIPTION FACTOR; TH1 CELLS; TH2 CELLS; TRETINOIN; TUMOR NECROSIS FACTOR-ALPHA;

EID: 33745069350     PISSN: 01728172     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00296-005-0076-1     Document Type: Article

References (25)

1. Romagnani S (1995) Biology of human TH1 and TH2 cells. J Clin Immunol 15:121-129
2. Hayashi M, Martinez OM, Garcia-Kennedy (1995) Expression of cytokines and immune mediators during chronic liver allograft rejection. Transplantation 60:1538-1553
3. Lafaille JJ (1998) The role of helper T cell subset in autoimmune disease. Cytokine Growth Factor Rev 9:139-151
4. Barton MT, Vitetta ES (1990) Interleukin-4 induces changes in the chromatin structure of the Ig switch region in resting B cells before switch recombination. J Exp Med 172:375-378
5. Ichiki T, Takahashi W, Watanabe T (1993) Regulation of the expression of human C germline transcript. J Immunol 150:5408-5417
6. Feldmann M, Brennan FM, Maini RN (1996) Role of cytokines in rheumatoid arthritis. Annu Rev Immunol 14:397-440
7. Feldmann M, Brennan FM, Maini RN (1996) Rheumatoid arthritis. Cell 85:307-310
8. Mathew JS, Sharma RP (2000) Effect of all-trans-retinoic acid on cytokine production in a murine macrophage cell line. Int J Immunopharmacol 22:693-706
9. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, Kollias G (1991) Transgenic mice expressing human tumor necrosis factor: a predictive genetic model of arthritis. EMBO J 10:4025-4031
10. Ishiyawa M, Hideyuki T, Shiga M (1996) A combined assay of cell viability and in vitro cytotoxity with a highly water-soluble tetrazolium salt, neutral red and crystal violet. Biol Pharm Bull 19:1518-1520
11. Diefenbach A, Schindler H, Rollinghoff M, Yokoyama WM, Bogdan C (1999) Requirement for type 2 NO synthase for IL-12 signaling in innate immunity. Science 284:951-955
12. Jiang XL, Dillehay DL, Everson MP, Tilden AB, Lamon EW (1992) Potentiation of IL-2-induced T-cell proliferation by retinoids. Int J Immunopharmacol 14:195-204
13. Sidell N, Ramsdell F (1988) Retinoic acid upregulates interleukin-2 receptors on activated human thymocytes. Cell Immunol 115:299-309
14. Felli MP, Vacca A, Meco D, Screpanti I, Farina AR, Maroder M, Martinotti S, Petrangeli E, Frati L, Gulino A (1991) Retinoic acid-induced down-regulation of the interleukin-2 promoter via cis-regulatory sequences containing an octamer motif. Mol Cell Biol 11:4771-4778
15. Kinoshita K, Yoo BS, Nozaki Y, Sugiyama M, Ikoma S, Ohno M, Funauchi M, Kanamaru A (2003) Retinoic acid reduces autoimmune renal injury and increases survival in NZB/WF1 mice. J Immunol 170:5793-5798
16. Racke MK, Burnett D, Pak SH, Albert PS, Cannella B, Raine CS, McFarlin DE, Scott DE (1995) Retinoid treatment of experimental allergic encephalomyelitis. IL-4 production correlates with improved disease course. J Immunol 154:450-458
17. Kaplan MH, Schindler U, Smiley ST, Grusby MJ (1996) Stato is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 4:313-319
18. Konta T, Xu Q, Furusu A, Nakayama K, Kitamura M (2001) Selective roles of retinoic acid receptor and retinoid X receptor in the suppression of apoptosis by all-trans-retinoic acid. J Biol Chem 16:12697-12701
19. Siebenlist U, Franzoso G, Brown K (1994) Structure, regulation and function of NF-κ. Annu Rev Cell Biol 10:405-455
20. Gerli R, Bistoni O, Russano A, Fiorucci S, Borgato L, Cesarotti ME, Lunardi C (2002) In vivo activated T cells in rheumatoid synovitis. Analysis of Th1- and Th2-type cytokine production at clonal level in different stages of disease. Clin Exp Immunol 129:549-555
21. Steiner G, Tohidast-Akrad M, Witzmann G, Vesely M, Studnicka-Benke A, Gal A, Kunaver M, Zenz P, Smolen JS (1999) Cytokine production by synovial T cells in rheumatoid arthritis. Rheumatology 38:202-213
22. Canete JD, Martinez SE, Farres J, Sanmarti R, Blay M, Gomez A, Salvador G, Munoz-Gomez J (2000) Differential Th1/Th2 cytokine patterns in chronic arthritis: interferon gamma is highly expressed in synovium of rheumatoid arthritis compared with seronegative spondyloarthropathies. Ann Rheum Dis 59:263-268
23. Dayer JM (2002) Interleukin 1 or tumor necrosis factor-alpha: which is the real target in rheumatoid arthritis? J Rheumatol 65:10-15
24. Bathon JM, Martin RW, Fleischmann RM et al (2000) A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis. N Engl J Med 343:1586-1593
25. Hallegua DS, Weisman MH (2002) Potential therapeutic uses of interleukin 1 receptor antagonists in human diseases. Ann Rheum Dis 61:960-967